Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Iveric Bio

Annexon’s ANX007 Misses GA Endpoint, But May Have Visual Acuity Path Forward

The ARCHER study did not show improvement in lesion growth, but still showed an improvement in best corrected visual acuity, potentially opening a pathway toward a pivotal trial.

Ophthalmic Clinical Trials

Allure Of Apellis Enhanced By Stellar Launch Of Syfovre

Rival Iveric may be in the process of being bought by Astellas but that has done nothing to dampen interest in Apellis and its geographic atrophy treatment, Syfovre, which was only launched in March yet reached Q1 sales of over $18m.

Launches Ophthalmic

Astellas Paying $5.9bn For Iveric To Boost Ophthalmology Presence

Astellas set to acquire private US firm to add to its strategic capabilities in ophthalmology focus area, along with another revenue pillar as it prepares for Xtandi expiry. 

Commercial Ophthalmic

Germany’s Complement Bets On Gene Therapy For Geographic Atrophy

US approval of Apellis's Syfovre has validated the complement approach for treating the advanced stage of age-related macular degeneration but a Munich-headquartered start-up believes its gene therapy will be a more potent and less burdensome alternative.

Commercial Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • Inception 4, Inc.
    • Ophthotech Corporation (OPHT)